share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MCKENZIE DIANA

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MCKENZIE DIANA

福泰制药 | 4:持股变动声明-董事 MCKENZIE DIANA
美股SEC公告 ·  05/03 16:23

Moomoo AI 已提取核心信息

On May 1, 2024, Diana McKenzie, associated with Vertex Pharmaceuticals Inc. (VRTX), engaged in transactions involving the company's common stock. McKenzie acquired 1,001 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, McKenzie's direct holdings in Vertex Pharmaceuticals totaled 2,436 shares. Additionally, it was reported that McKenzie holds 207 shares indirectly through a trust. The transactions have been marked as completed.
On May 1, 2024, Diana McKenzie, associated with Vertex Pharmaceuticals Inc. (VRTX), engaged in transactions involving the company's common stock. McKenzie acquired 1,001 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, McKenzie's direct holdings in Vertex Pharmaceuticals totaled 2,436 shares. Additionally, it was reported that McKenzie holds 207 shares indirectly through a trust. The transactions have been marked as completed.
2024年5月1日,与Vertex Pharmicals Inc.(VRTX)关联的戴安娜·麦肯齐参与了涉及该公司普通股的交易。麦肯齐免费收购了1,001股股票,这通常表示授予或奖励。同一天,她出售了1,168股股票;但是,交易价格没有披露。这些交易之后,麦肯齐在Vertex Pharmicals的直接持股总额为2436股。此外,据报道,麦肯齐通过信托间接持有207股股票。交易已标记为已完成。
2024年5月1日,与Vertex Pharmicals Inc.(VRTX)关联的戴安娜·麦肯齐参与了涉及该公司普通股的交易。麦肯齐免费收购了1,001股股票,这通常表示授予或奖励。同一天,她出售了1,168股股票;但是,交易价格没有披露。这些交易之后,麦肯齐在Vertex Pharmicals的直接持股总额为2436股。此外,据报道,麦肯齐通过信托间接持有207股股票。交易已标记为已完成。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息